20 related articles for article (PubMed ID: 35381778)
1. Development of
Hosseini SM; Mohammadnejad J; Yousefnia H; Alirezapour B; Rezayan AH
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7779-7791. PubMed ID: 37029816
[TBL] [Abstract][Full Text] [Related]
2. The Necrosis-Avid Small Molecule HQ4-DTPA as a Multimodal Imaging Agent for Monitoring Radiation Therapy-Induced Tumor Cell Death.
Stammes MA; Maeda A; Bu J; Scollard DA; Kulbatski I; Medeiros PJ; Sinisi R; Dubikovskaya EA; Snoeks TJ; van Beek ER; Chan AB; Löwik CW; DaCosta RS
Front Oncol; 2016; 6():221. PubMed ID: 27818949
[TBL] [Abstract][Full Text] [Related]
3. A Robust Method for Assaying the Immunoreactive Fraction in Nonequilibrium Systems.
Denoël T; Pedrelli L; Pantaleo G; Prior JO
Pharmaceuticals (Basel); 2019 Dec; 12(4):. PubMed ID: 31817013
[TBL] [Abstract][Full Text] [Related]
4. Expression of MUC1 in different tumours and its clinical significance (Review).
Lan Y; Ni W; Tai G
Mol Clin Oncol; 2022 Dec; 17(6):161. PubMed ID: 36479256
[TBL] [Abstract][Full Text] [Related]
5. Development of [⁶⁴Cu]-DOTA-PR81 radioimmunoconjugate for MUC-1 positive PET imaging.
Alirezapour B; Rasaee MJ; Jalilian AR; Rajabifar S; Mohammadnejad J; Paknejad M; Maadi E; Moradkhani S
Nucl Med Biol; 2016 Jan; 43(1):73-80. PubMed ID: 26453525
[TBL] [Abstract][Full Text] [Related]
6. Preparation, quality control, and biodistribution assessment of [
Abbas Abadi S; Alirezapour B; Kertész I; Rasaee MJ; Mohammadnejad J; Paknejad M; Yousefnia H; Zolghadri S
J Labelled Comp Radiopharm; 2021 Apr; 64(4):168-180. PubMed ID: 33269473
[TBL] [Abstract][Full Text] [Related]
7. Preparation and biological evaluation of (177)Lu conjugated PR81 for radioimmunotherapy of breast cancer.
Salouti M; Babaei MH; Rajabi H; Rasaee Mj
Nucl Med Biol; 2011 Aug; 38(6):849-55. PubMed ID: 21843781
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunotherapy of MCF7 breast cancer cell line with 131I-PR81 monoclonal antibody against MUC1: comparison of direct and indirect radioiodination methods.
Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Hasan ZM; Salouti M; Gandomkar M; Sadri K
Hum Antibodies; 2010; 19(1):15-25. PubMed ID: 20555127
[TBL] [Abstract][Full Text] [Related]
9. A new radiopharmaceutical compound (131I-PR81) for radioimmunotherapy of breast cancer: labeling of antibody and its quality control.
Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Zahir MH; Salouti M; Rajabi AB; Mazidi M
Hum Antibodies; 2010; 19(4):79-88. PubMed ID: 21178279
[TBL] [Abstract][Full Text] [Related]
10. Preparation and preclinical characterization of
Alirezapour B; Ashkezari MD; Fini MM; Rasaee MJ; Mohammadnejad J; Paknejad M; Maadi E; Yousefnia H; Zolghadri S
J Cancer Res Ther; 2022; 18(1):158-167. PubMed ID: 35381778
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
